Home Department: Bioengineering
Mentor: Calvin Kuo, Medicine (Hematology)

“Enhancing Immunotherapy Response by Combinational Approach of Immune Checkpoint Blockade Using Organoids”

Research has shown that implementing an immune checkpoint blockade to interrupt immune inhibitory pathways can facilitate a more robust immune response to cancer and improve cancer treatment, but its combinational approach still has to be optimized to enhance the efficacy. Edward’s Stanford Bio-X summer research will assess if human tumor samples grown as 3-dimensional “organoids” can be used to optimize a combinational approach of immune checkpoint blockade in cancer immunotherapy.